Product Information
SYMTUZA 800-150-200-10 MG TAB is a brand product labeled by Janssen Products LP, priced at $152.8673 per EA under NDC 59676080030. Its NADAC has been published 407 times since Nov 21, 2018.
FDA first approved this application on Jul 17, 2018.
SYMTUZA 800-150-200-10 MG TAB
Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamideStrength
150; 800; 200; 10 mg/1; mg/1; mg/1; mg/1
Manufacturer
Janssen Products LPNDC
59676080030
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDEApproval Type
New Drug (NDA)
FDA Application
NDA210455FDA Approved
7/17/2018
On Market Since
7/17/2018
Pharmacological Classes
Price Statistics
The NADAC for SYMTUZA 800-150-200-10 MG TAB has been published 407 times since Nov 21, 2018, and over the history we have for it it has risen 37.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $152.8673 per EA |
|---|---|
| All-time high | $152.9634 (Jul 15, 2026) |
| All-time low | $111.4385 (Nov 21, 2018) |
| 52-week high | $152.9634 |
| 52-week low | $152.2976 |
| Median price | $138.7581 |
| Average price | $139.1635 |
| Largest weekly change | +7.0% (Feb 1, 2023) |
| Weeks tracked | 407 |
| Tracking since | Nov 21, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Janssen Products LP manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cytochrome P450 3A Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SYMTUZA 800-150-200-10 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for SYMTUZA 800-150-200-10 MG TAB, manufactured by Janssen Products LP, is $152.8673 per EA (NDC 59676080030), effective Sep 30, 2026.
How has the price of SYMTUZA 800-150-200-10 MG TAB changed over time?
Over the history we have for it, the NADAC for SYMTUZA 800-150-200-10 MG TAB has risen 37.2%. It has been tracked across 407 weekly CMS publications since Nov 21, 2018.
What are the highest and lowest recorded NADAC prices for SYMTUZA 800-150-200-10 MG TAB?
Since Nov 21, 2018, the NADAC for SYMTUZA 800-150-200-10 MG TAB has ranged from a low of $111.4385 (Nov 21, 2018) to a high of $152.9634 (Jul 15, 2026), with a median of $138.7581 per EA.
Are there cheaper alternatives to SYMTUZA 800-150-200-10 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of SYMTUZA 800-150-200-10 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SYMTUZA 800-150-200-10 MG TAB?
SYMTUZA 800-150-200-10 MG TAB (NDC 59676080030) is labeled by Janssen Products LP, and CMS classifies it as a brand product.